- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks
U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
156
Mid-Large Cap Stocks
156 companies
Arcellx
Market Cap: US$3.3b
Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.
ACLX
US$58.45
7D
3.9%
1Y
10.7%
Ionis Pharmaceuticals
Market Cap: US$5.2b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$32.99
7D
0.7%
1Y
-12.3%
Waters
Market Cap: US$20.6b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$351.60
7D
0.2%
1Y
-2.5%
Metsera
Market Cap: US$2.6b
A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.
MTSR
US$25.61
7D
3.4%
1Y
n/a
Mirum Pharmaceuticals
Market Cap: US$2.2b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$45.28
7D
0.09%
1Y
82.9%
Veracyte
Market Cap: US$2.2b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$28.49
7D
-8.7%
1Y
21.8%
BioMarin Pharmaceutical
Market Cap: US$11.3b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$58.27
7D
-2.6%
1Y
-24.3%
BGM Group
Market Cap: US$1.7b
Through its subsidiaries, operates as a pharmaceutical and chemical company in China.
BGM
US$11.52
7D
2.0%
1Y
n/a
PTC Therapeutics
Market Cap: US$3.7b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.
PTCT
US$45.31
7D
6.6%
1Y
33.1%
West Pharmaceutical Services
Market Cap: US$14.8b
Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
WST
US$210.68
7D
-1.9%
1Y
-40.5%
ImmunityBio
Market Cap: US$2.2b
A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.
IBRX
US$2.67
7D
27.8%
1Y
-65.5%
Amicus Therapeutics
Market Cap: US$1.8b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$5.95
7D
-2.1%
1Y
-37.4%
Tarsus Pharmaceuticals
Market Cap: US$1.8b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$43.50
7D
-7.7%
1Y
12.8%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
Twist Bioscience
Market Cap: US$1.8b
Manufactures and sells synthetic DNA-based products.
TWST
US$30.10
7D
-7.7%
1Y
-35.3%
Edgewise Therapeutics
Market Cap: US$1.5b
A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.
EWTX
US$14.45
7D
-1.7%
1Y
-20.5%
Agios Pharmaceuticals
Market Cap: US$1.6b
A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.
AGIO
US$28.26
7D
0.8%
1Y
-19.3%
Protagonist Therapeutics
Market Cap: US$2.7b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$44.41
7D
1.1%
1Y
39.0%
Avidity Biosciences
Market Cap: US$3.4b
A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).
RNA
US$28.97
7D
1.0%
1Y
0.9%
Kymera Therapeutics
Market Cap: US$1.9b
A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.
KYMR
US$30.02
7D
-2.4%
1Y
-15.7%
Biohaven
Market Cap: US$2.0b
Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.
BHVN
US$15.82
7D
-21.9%
1Y
-58.9%
Nuvalent
Market Cap: US$5.1b
A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
NUVL
US$71.00
7D
-0.8%
1Y
-2.3%
Endo
Market Cap: US$1.6b
A specialty pharmaceutical company, develops, manufactures, markets, and sells various pharmaceutical products in the United States and internationally.
NDOI
US$21.20
7D
1.4%
1Y
n/a
Apellis Pharmaceuticals
Market Cap: US$2.1b
A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.
APLS
US$16.36
7D
-8.1%
1Y
-61.0%
Blueprint Medicines
Market Cap: US$6.3b
A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.
BPMC
US$99.49
7D
0.7%
1Y
-6.7%
Natera
Market Cap: US$20.7b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$149.40
7D
-8.1%
1Y
37.7%
Dyne Therapeutics
Market Cap: US$1.3b
A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
DYN
US$11.74
7D
3.9%
1Y
-59.2%
Crinetics Pharmaceuticals
Market Cap: US$2.9b
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
CRNX
US$31.21
7D
-4.6%
1Y
-39.9%
Aurinia Pharmaceuticals
Market Cap: US$1.1b
A biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
AUPH
US$8.15
7D
0.5%
1Y
41.2%
MannKind
Market Cap: US$1.4b
A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.
MNKD
US$4.56
7D
-1.5%
1Y
-0.7%
Regencell Bioscience Holdings
Market Cap: US$4.5b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$402.00
7D
89.6%
1Y
7,618.9%
MiMedx Group
Market Cap: US$1.0b
Develops and distributes placental tissue allografts for various sectors of healthcare.
MDXG
US$7.09
7D
-4.4%
1Y
-10.1%
Amneal Pharmaceuticals
Market Cap: US$2.3b
A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.
AMRX
US$7.50
7D
0.5%
1Y
11.1%
Alkermes
Market Cap: US$5.0b
A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
ALKS
US$31.21
7D
2.7%
1Y
27.6%
Alvotech
Market Cap: US$3.2b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$10.46
7D
11.5%
1Y
-22.5%
Immunovant
Market Cap: US$2.3b
A clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
IMVT
US$13.92
7D
-2.7%
1Y
-55.8%